AN2 Therapeutics Inc
NASDAQ:ANTX
AN2 Therapeutics Inc
NASDAQ:ANTX
Price:
4.33
USD
-2.91%
Market Closed
Market Cap:
$155.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
AN2 Therapeutics Inc
NASDAQ:ANTX
|
US |
|
L
|
LVMH Moet Hennessy Louis Vuitton SE
DUS:MOH
|
FR |
|
Pirelli & C SpA
MIL:PIRC
|
IT |
|
Gilead Sciences Inc
NASDAQ:GILD
|
US |
|
C
|
CTI Biopharma Corp
F:CEPS
|
US |
|
AeroVironment Inc
NASDAQ:AVAV
|
US |
|
SBC Exports Ltd
NSE:SBC
|
IN |
|
M
|
Mobotix AG
XBER:MBQ
|
DE |
|
H
|
Hartford Financial Services Group Inc
XBER:HFF
|
US |
Wall St Price Targets
ANTX Price Targets Summary
AN2 Therapeutics Inc
AN2 Therapeutics Inc
Wall Street analysts forecast ANTX stock price to drop over the next 12 months.
According to Wall Street analysts, the average 1-year price target for ANTX is 1.02 USD with a low forecast of 1.01 USD and a high forecast of 1.05 USD.
Lowest Forecast
Price Target
1.01
USD
77% Downside
Average Forecast
Price Target
1.02
USD
76% Downside
Highest Forecast
Price Target
1.05
USD
76% Downside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ANTX's stock price target?
Price Target
1.02
USD
1.02
USD
According to Wall Street analysts, the average 1-year price target for ANTX is 1.02 USD with a low forecast of 1.01 USD and a high forecast of 1.05 USD.
